 Warfarin, a vitamin K antagonist VKA, is the most frequently prescribed oral anticoagulant. Warfarin-associated major hemorrhage occurs at a rate of 1.7 to 3.4 in routine clinical practice and warrants rapid reversal of anticoagulation by correcting supratherapeutic international normalized ratio INR values. 